Plasma chemerin level in metabolic syndrome

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 5986-5991

  Wang, D ^a   Yuan, G Y ^a   Wang, X Z ^a   Jia, J ^a   Di, L L ^a   Yang, L ^a   Chen, X ^a   Qian, F F ^a   Chen, J J ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Chemerin; Metabolic syndrome

Indexed keywords

CHEMERIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHEMOKINES; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; WAIST CIRCUMFERENCE;

EID: 84888395980     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.November.26.8     Document Type: Article

References (13)

1. Ailhaud G (2006). Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol. 329: 570-577.
2. Bozaoglu K, Bolton K, McMillan J, Zimmet P, et al. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148: 4687-4694.
3. Ding X.D and Fan J.G (2009). Hepatic insulin resistance mechanisms and consequences. Chin. J. Diabetes 1: 297-301.
4. Eckel R.H, Grundy S.M and Zimmet P.Z (2005). The metabolic syndrome. Lancet 365: 1415-1428.
5. Ford E.S and Giles W.H (2003). A comparison of the prevalence of the metabolic syndrome using two proposed defnitions. Diabetes Care 26: 575-581.
6. Goralski K.B, McCarthy T.C, Hanniman E.A, Zabel B.A, et al. (2007). Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282: 28175-28188.
7. Guan Y.Q, Zhao X.X and Sun L.L (2010). The uighur metabolic syndrome patients of chemerin expression of and related factors. Chin. J. Hypertens. 18: 733-738.
8. Sell H, Laurencikiene J, Taube A, Eckardt K, et al. (2009). Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58: 2731-2740.
9. Song X.X and Ji L.N (2005). International Diabetes Federation global consensus on the defnition of the metabolic syndrome. Chin. J. Diabetes 13: 178-180.
10. Stejskal D, Karpisek M, Hanulova Z and Svestak M (2008). Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech Repub. 152: 217-221.
11. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, et al. (2008). Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582: 573-578.
12. Wittamer V, Franssen J.D, Vulcano M, Mirjolet J.F, et al. (2003). Specifc recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human infammatory fuids. J. Exp. Med. 198: 977-985.
13. Yang Z.J, Liu J, Ge J.P, Chen L, et al. (2012). Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur. Heart J. 33: 213-220.